Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Extrawell Pharmaceutical Holdings Limited ( (HK:0858) ) has shared an announcement.
Extrawell Pharmaceutical Holdings Limited has announced that, effective 1 January 2026, the building name of its Hong Kong head office and principal place of business will change from Devon House to FWD Tower, with the full updated address now stated as Suites 2206–08, 22/F., FWD Tower, Taikoo Place, 979 King’s Road, Quarry Bay, Hong Kong. The change is purely nominal and does not involve any relocation, meaning the physical location and operational footprint of the company in Hong Kong remain unchanged, signalling no direct impact on ongoing business activities or stakeholder arrangements beyond administrative address updates.
The most recent analyst rating on (HK:0858) stock is a Hold with a HK$0.09 price target. To see the full list of analyst forecasts on Extrawell Pharmaceutical Holdings Limited stock, see the HK:0858 Stock Forecast page.
More about Extrawell Pharmaceutical Holdings Limited
Extrawell Pharmaceutical Holdings Limited is a Hong Kong-listed pharmaceutical company engaged in the research, development and commercialization of medical and healthcare products, with its corporate and operational base in Hong Kong serving regional and mainland China markets.
Average Trading Volume: 2,461,525
Technical Sentiment Signal: Hold
Current Market Cap: HK$216.8M
See more insights into 0858 stock on TipRanks’ Stock Analysis page.